[
    {
        "title": "Document and Entity Information", 
        "Document and Entity Information": {
            "Entity Registrant Name": {
                "value": "AbbVie Inc.", 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Entity Central Index Key": {
                "value": 1551152, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Document Type": {
                "value": "10-Q", 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Document Period End Date": {
                "value": "31-Mar-15", 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Amendment Flag": {
                "value": "false", 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Current Fiscal Year End Date": {
                "value": -19, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Entity Current Reporting Status": {
                "value": "Yes", 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Entity Filer Category": {
                "value": "Large Accelerated Filer", 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Entity Common Stock, Shares Outstanding": {
                "value": 1593076097, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Document Fiscal Year Focus": {
                "value": 2015, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Document Fiscal Period Focus": {
                "value": "Q1", 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }
    }, 
    {
        "title": "Consolidated Statements of Earnings (USD $) In Millions, except Per Share data, unless otherwise specified", 
        "Condensed Consolidated Statements of Earnings": {
            "Net sales": [
                {
                    "value": 5040, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 4563, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Cost of products sold": [
                {
                    "value": 942, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 1100, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Selling, general and administrative": [
                {
                    "value": 1473, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 1340, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Research and development": [
                {
                    "value": 811, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 772, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Acquired in-process research and development": {
                "value": 127, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Total operating costs and expenses": [
                {
                    "value": 3353, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 3212, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Operating earnings": [
                {
                    "value": 1687, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 1351, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Interest expense, net": [
                {
                    "value": 126, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 65, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Net foreign exchange loss": [
                {
                    "value": 164, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 3, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Other expense (income), net": [
                {
                    "value": 1, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -3, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Earnings before income tax expense": [
                {
                    "value": 1396, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 1286, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Income tax expense": [
                {
                    "value": 374, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 306, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Net earnings": [
                {
                    "value": 1022, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 980, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Per share data": {
            "Basic earnings per share (in dollars per share)": [
                {
                    "value": 0.64, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 0.61, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Diluted earnings per share (in dollars per share)": [
                {
                    "value": 0.63, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 0.61, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Cash dividends declared per common share (in dollars per share)": [
                {
                    "value": 0.51, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 0.42, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Weighted-average basic shares outstanding (in shares)": [
                {
                    "value": 1595, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 1595, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Weighted-average diluted shares outstanding (in shares)": [
                {
                    "value": 1608, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 1609, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }
    }, 
    {
        "title": "Consolidated Statements of Comprehensive Income (USD $) In Millions, unless otherwise specified", 
        "Consolidated Statements of Comprehensive Income": {
            "Net earnings": [
                {
                    "value": 1022, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 980, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Foreign currency translation adjustments, net of tax benefit of $(129) and $(3) for the three months ended March 31, 2015 and 2014, respectively": [
                {
                    "value": -549, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -29, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Pension and post-employment benefits, net of tax expense of $10 and $4 for the three months ended March 31, 2015 and 2014, respectively": [
                {
                    "value": 55, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 12, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Unrealized gains on marketable equity securities, net of tax expense of $- for the three months ended March 31, 2015": {
                "value": 1, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Hedging activities, net of tax expense of $2 for both the three months ended March 31, 2015 and 2014": [
                {
                    "value": 57, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 33, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Other comprehensive (loss) income": [
                {
                    "value": -436, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 16, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Comprehensive income": [
                {
                    "value": 586, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 996, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }
    }, 
    {
        "title": "Consolidated Statements of Comprehensive Income (Parenthetical) (USD $) In Millions, unless otherwise specified", 
        "Consolidated Statements of Comprehensive Income": {
            "Foreign currency translation adjustments, tax (benefit) expense": [
                {
                    "value": -129, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -3, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Pension and post-employment benefits, tax (benefit) expense": [
                {
                    "value": 10, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 4, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Hedging activities, tax expense (benefit)": [
                {
                    "value": 2, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 2, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }
    }, 
    {
        "title": "Consolidated Balance Sheets (USD $)", 
        "In Millions, unless otherwise specified Current assets": {
            "Cash and equivalents": [
                {
                    "value": 7906, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 8348, 
                    "date": "dec 31 2014"
                }
            ], 
            "Short-term investments": [
                {
                    "value": 18, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 26, 
                    "date": "dec 31 2014"
                }
            ], 
            "Accounts and other receivables, net": [
                {
                    "value": 4214, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 3735, 
                    "date": "dec 31 2014"
                }
            ], 
            "Inventories, net": [
                {
                    "value": 1022, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 1124, 
                    "date": "dec 31 2014"
                }
            ], 
            "Income tax receivable": [
                {
                    "value": 142, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 556, 
                    "date": "dec 31 2014"
                }
            ], 
            "Deferred income taxes": [
                {
                    "value": 1056, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 896, 
                    "date": "dec 31 2014"
                }
            ], 
            "Prepaid expenses and other": [
                {
                    "value": 1050, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 1403, 
                    "date": "dec 31 2014"
                }
            ], 
            "Total current assets": [
                {
                    "value": 15408, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 16088, 
                    "date": "dec 31 2014"
                }
            ], 
            "Investments": [
                {
                    "value": 93, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 92, 
                    "date": "dec 31 2014"
                }
            ], 
            "Property and equipment, net": [
                {
                    "value": 2431, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 2485, 
                    "date": "dec 31 2014"
                }
            ], 
            "Intangible assets, net of amortization": [
                {
                    "value": 1478, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 1513, 
                    "date": "dec 31 2014"
                }
            ], 
            "Goodwill": [
                {
                    "value": 5534, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 5862, 
                    "date": "dec 31 2014"
                }
            ], 
            "Other assets": [
                {
                    "value": 1755, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 1507, 
                    "date": "dec 31 2014"
                }
            ], 
            "Total assets": [
                {
                    "value": 26699, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 27547, 
                    "date": "dec 31 2014"
                }
            ]
        }, 
        "Current liabilities": {
            "Short-term borrowings": [
                {
                    "value": 569, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 425, 
                    "date": "dec 31 2014"
                }
            ], 
            "Current portion of long-term debt and lease obligations": [
                {
                    "value": 4021, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 4021, 
                    "date": "dec 31 2014"
                }
            ], 
            "Accounts payable and accrued liabilities": [
                {
                    "value": 6460, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 6954, 
                    "date": "dec 31 2014"
                }
            ], 
            "Total current liabilities": [
                {
                    "value": 11050, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 11400, 
                    "date": "dec 31 2014"
                }
            ], 
            "Long-term liabilities": [
                {
                    "value": 3589, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 3840, 
                    "date": "dec 31 2014"
                }
            ], 
            "Long-term debt and lease obligations": [
                {
                    "value": 10683, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 10565, 
                    "date": "dec 31 2014"
                }
            ], 
            "Commitments and contingencies": [
                {
                    "value": "  ", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": "  ", 
                    "date": "dec 31 2014"
                }
            ]
        }, 
        "Stockholders' equity": {
            "Common stock, $0.01 par value, authorized 4,000,000,000 shares, issued 1,617,065,448 and 1,609,519,046 shares as of March 31, 2015 and December 31, 2014, respectively": [
                {
                    "value": 16, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 16, 
                    "date": "dec 31 2014"
                }
            ], 
            "Common stock held in treasury, at cost, 23,989,351 and 18,129,715 shares as of March 31, 2015 and December 31, 2014, respectively": [
                {
                    "value": -1314, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -972, 
                    "date": "dec 31 2014"
                }
            ], 
            "Additional paid-in-capital": [
                {
                    "value": 4403, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 4194, 
                    "date": "dec 31 2014"
                }
            ], 
            "Retained earnings": [
                {
                    "value": 739, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 535, 
                    "date": "dec 31 2014"
                }
            ], 
            "Accumulated other comprehensive loss": [
                {
                    "value": -2467, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -2031, 
                    "date": "dec 31 2014"
                }
            ], 
            "Total stockholders' equity": [
                {
                    "value": 1377, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 1742, 
                    "date": "dec 31 2014"
                }
            ], 
            "Total liabilities and equity": [
                {
                    "value": 26699, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 27547, 
                    "date": "dec 31 2014"
                }
            ]
        }
    }, 
    {
        "title": "Consolidated Balance Sheets (Parenthetical) (USD $)", 
        "Consolidated Balance Sheets": {
            "Common stock, par value (in dollars per share)": [
                {
                    "value": 0.01, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 0.01, 
                    "date": "dec 31 2014"
                }
            ], 
            "Common stock, authorized (in shares)": [
                {
                    "value": 4000000000, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 4000000000, 
                    "date": "dec 31 2014"
                }
            ], 
            "Common stock, issued (in shares)": [
                {
                    "value": 1617065448, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 1609519046, 
                    "date": "dec 31 2014"
                }
            ], 
            "Common stock held in treasury, at cost (in shares)": [
                {
                    "value": 23989351, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 18129715, 
                    "date": "dec 31 2014"
                }
            ]
        }
    }, 
    {
        "title": "Consolidated Statements of Cash Flows (USD $) In Millions, unless otherwise specified", 
        "Cash flows from operating activities": {
            "Net earnings": [
                {
                    "value": 1022, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 980, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Adjustments to reconcile net earnings to net cash from operating activities:": {
            "Depreciation": [
                {
                    "value": 90, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 89, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Amortization of intangible assets": [
                {
                    "value": 68, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 110, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Stock-based compensation": [
                {
                    "value": 119, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 106, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Upfront costs related to collaborations": {
                "value": 127, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Other, net": [
                {
                    "value": 249, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -47, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Changes in operating assets and liabilities, net of acquisitions:": {
            "Accounts and other receivables": [
                {
                    "value": -544, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 167, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Inventories": [
                {
                    "value": -75, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 50, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Prepaid expenses and other assets": [
                {
                    "value": 341, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -219, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Accounts payable and other liabilities": [
                {
                    "value": 188, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -612, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Cash flows from operating activities": [
                {
                    "value": 1585, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 624, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Cash flows from investing activities": {
            "Acquisitions and investments, net of cash acquired": {
                "value": -736, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Acquisitions of property and equipment": [
                {
                    "value": -145, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -137, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Purchases of investment securities": {
                "value": -660, 
                "date": "mar 31 2014"
            }, 
            "Sales and maturities of investment securities": {
                "value": 8, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Cash flows from investing activities": [
                {
                    "value": -873, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -797, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Cash flows from financing activities": {
            "Net change in short-term borrowings": [
                {
                    "value": 144, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -410, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Dividends paid": [
                {
                    "value": -786, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -641, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Debt issuance costs": {
                "value": -59, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Purchases of treasury stock": [
                {
                    "value": -342, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -329, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Proceeds from the exercise of stock options": [
                {
                    "value": 47, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 85, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Other, net": [
                {
                    "value": 66, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 18, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Cash flows from financing activities": [
                {
                    "value": -930, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -1277, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Effect of exchange rate changes on cash and equivalents": [
                {
                    "value": -224, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -5, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Net decrease in cash and equivalents": [
                {
                    "value": -442, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -1455, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Cash and equivalents, beginning of period": [
                {
                    "value": 8348, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 9595, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Cash and equivalents, end of period": [
                {
                    "value": 7906, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 8140, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }
    }, 
    {
        "title": "Background and Basis of Presentation", 
        "Background and Basis of Presentation": {
            "Background and Basis of Presentation": {
                "value": "Note 1Background and Basis of Presentation", 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }
    }, 
    {
        "title": "Supplemental Financial Information", 
        "Supplemental Financial Information": {
            "Supplemental Financial Information": {
                "value": "Note 2Supplemental Financial Information", 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }
    }, 
    {
        "title": "Earnings Per Share", 
        "Earnings Per Share": {
            "Earnings Per Share": {
                "value": "Note 3Earnings Per Share", 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }
    }, 
    {
        "title": "Acquisitions, Collaborations and Other Arrangements", 
        "Acquisitions, Collaborations and Other Arrangements": {
            "Acquisitions, Collaborations and Other Arrangements": {
                "value": "Note 4Acquisitions, Collaborations and Other Arrangements", 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }
    }, 
    {
        "title": "Goodwill and Intangible Assets", 
        "Goodwill and Intangible Assets": {
            "Goodwill and Intangible Assets": {
                "value": "Note 5Goodwill and Intangible Assets", 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }
    }, 
    {
        "title": "Restructuring Plans", 
        "Restructuring Plans": {
            "Restructuring Plans": {
                "value": "Note 6Restructuring Plans", 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }
    }, 
    {
        "title": "Financial Instruments and Fair Value Measures", 
        "Financial Instruments and Fair Value Measures": {
            "Financial Instruments and Fair Value Measures": {
                "value": "Note 7Financial Instruments and Fair Value Measures", 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }
    }, 
    {
        "title": "Post-Employment Benefits", 
        "Post-Employment Benefits": {
            "Post-Employment Benefits": {
                "value": "Note 8Post-Employment Benefits", 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }
    }, 
    {
        "title": "Equity", 
        "Equity": {
            "Equity": {
                "value": "Note 9Equity", 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }
    }, 
    {
        "title": "Income Taxes", 
        "Income Taxes": {
            "Income Taxes": {
                "value": "Note 10Income Taxes", 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }
    }, 
    {
        "title": "Legal Proceedings and Contingencies", 
        "Legal Proceedings and Contingencies": {
            "Legal Proceedings and Contingencies": {
                "value": "Note 11Legal Proceedings and Contingencies", 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }
    }, 
    {
        "title": "Segment Information", 
        "Segment Information": {
            "Segment Information": {
                "value": "Note 12Segment Information", 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }
    }, 
    {
        "title": "Supplemental Financial Information (Tables)", 
        "Supplemental Financial Information Schedule of interest expense, net": {
            "Schedule of inventories, net": [
                {
                    "value": "(in millions)", 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": "March 31,"
                }, 
                {
                    "value": "December 31,"
                }
            ], 
            "Schedule of property and equipment, net": [
                {
                    "value": "(in millions)", 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": "March 31,"
                }, 
                {
                    "value": "December 31,"
                }
            ]
        }
    }, 
    {
        "title": "Goodwill and Intangible Assets (Tables)", 
        "Goodwill and Intangible Assets": {
            "Schedule of intangible assets": [
                {
                    "value": "March 31, 2015"
                }, 
                {
                    "value": "December 31, 2014"
                }
            ]
        }
    }, 
    {
        "title": "Restructuring Plans (Tables) (Restructuring Plan 2014 and Prior Years)", 
        "Restructuring Plan 2014 and Prior Years Restructuring Plans": {
            "Summary of the cash activity in the restructuring reserve": {
                "value": "(in millions)", 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }
    }, 
    {
        "title": "Financial Instruments and Fair Value Measures (Tables)", 
        "Summary of the bases used to measure certain assets and liabilities that are carried at fair value on a recurring basis in the condensed consolidated balance sheets": {
            "Schedule of the carrying values and fair values of certain financial instruments": [
                {
                    "value": "Book values"
                }, 
                {
                    "value": "Approximate fair values"
                }
            ]
        }
    }, 
    {
        "title": "Post-Employment Benefits (Tables) (AbbVie sponsored plans)", 
        "AbbVie sponsored plans Employee Benefit Plans Summary of net periodic benefit cost relating to the company's defined benefit and other post-employment plans": {}
    }, 
    {
        "title": "Equity (Tables)", 
        "Schedule of the significant amounts reclassified out of each component of accumulated other comprehensive loss": {}
    }, 
    {
        "title": "Segment Information (Tables)", 
        "Segment Information": {
            "Schedule of consolidated financial information by segment": {
                "value": "Three months ended"
            }
        }
    }, 
    {
        "title": "Background and Basis of Presentation (Details) (USD $) In Millions, unless otherwise specified", 
        "Background and Basis of Presentation": {
            "Number of wholesalers": {
                "value": 3, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Separation-related expenses": [
                {
                    "value": 104, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 80, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "AbbVie sponsored plans Background and Basis of Presentation": {
            "Percentage of outstanding common stock distributed to Abbott Laboratories' shareholders": {
                "value": 1, 
                "time": "0 months ended", 
                "date": "jan 02 2013"
            }
        }, 
        "Abbott | Separation agreement Operations and assets (net of liabilities) on which legal transfer of did not occur with the separation of the entity": {
            "Net sales": {
                "value": 49, 
                "time": "12 months ended", 
                "date": "dec 31 2014"
            }
        }
    }, 
    {
        "title": "Supplemental Financial Information (Details) (USD $) In Millions, unless otherwise specified", 
        "Interest Expense, net": {
            "Interest expense": [
                {
                    "value": 132, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 70, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Interest income": [
                {
                    "value": -6, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -5, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Interest expense, net": [
                {
                    "value": 126, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 65, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Inventories, Net": {
            "Finished goods": [
                {
                    "value": 291, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 341, 
                    "date": "dec 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Work-in-process": [
                {
                    "value": 568, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 629, 
                    "date": "dec 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Raw materials": [
                {
                    "value": 163, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 154, 
                    "date": "dec 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Inventories, net": [
                {
                    "value": 1022, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 1124, 
                    "date": "dec 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Property and Equipment, Net": {
            "Property and equipment, gross": [
                {
                    "value": 6988, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 7105, 
                    "date": "dec 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Less accumulated depreciation": [
                {
                    "value": -4557, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -4620, 
                    "date": "dec 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Property and equipment, net": [
                {
                    "value": 2431, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 2485, 
                    "date": "dec 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Depreciation expense": [
                {
                    "value": 90, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 89, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Pharmacyclics Inc Interest Expense, net": {
            "Interest expense, net": {
                "value": 59, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }
    }, 
    {
        "title": "Earnings Per Share (Details) (USD $) In Millions, unless otherwise specified", 
        "Anti-dilutive securities excluded from the computation of earnings per common share": {
            "Earnings allocable to participating securities (in dollars)": [
                {
                    "value": 5, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 4, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "RSAs & RSUs Anti-dilutive securities excluded from the computation of earnings per common share": {
            "Anti-dilutive securities excluded from the computation of earnings per common share (in shares)": [
                {
                    "value": 3, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 4, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Stock-based compensation plans Anti-dilutive securities excluded from the computation of earnings per common share": {
            "Anti-dilutive securities excluded from the computation of earnings per common share (in shares)": [
                {
                    "value": 0.5, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 1, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }
    }, 
    {
        "title": "Acquisitions, Collaborations and Other Arrangements (Details) (USD $)", 
        "Acquisitions": {
            "Cash outflows related to acquisitions, collaborations and other arrangements": {
                "value": 736000000, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Acquired in-process research and development": {
                "value": 127000000, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }, 
        "Collaborations and Other Arrangements": {
            "Financing cost recorded in interest expense": {
                "value": 59000000, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }, 
        "Calico Life Sciences LLC Acquisitions": {
            "Cash outflows related to acquisitions, collaborations and other arrangements": {
                "value": 500000000, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }, 
        "C2N Diagnostics Acquisitions": {
            "Additional contribution": {
                "value": 685000000, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }, 
        "Term loan facility | Bridge Term Loan Agreement Collaborations and Other Arrangements": {
            "Debt term": {
                "value": "364 days", 
                "time": "0 months ended", 
                "date": "mar 27 2015"
            }, 
            "Drawn amount": {
                "value": 0, 
                "time": "0 months ended", 
                "date": "mar 27 2015"
            }, 
            "Maximum borrowing of term loan facility": {
                "value": 18000000000, 
                "time": "0 months ended", 
                "date": "mar 27 2015"
            }
        }, 
        "IPR&D Acquisitions": {
            "Acquired in-process research and development": {
                "value": 127000000, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }, 
        "IPR&D | C2N Diagnostics Acquisitions": {
            "Initial upfront payment": {
                "value": 100000000, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }, 
        "Subsequent event | Forecast | Senior notes Collaborations and Other Arrangements": {
            "Debt face amount": {
                "value": 17000000000, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }, 
        "Pharmacyclics Inc Collaborations and Other Arrangements": {
            "Purchase price (in dollars per share)": {
                "value": 261.25, 
                "date": "mar 04 2015"
            }, 
            "Percentage of cash consideration": {
                "value": 0.58, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Percentage of share consideration": {
                "value": 0.42, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }, 
        "Pharmacyclics Inc | Scenario One Collaborations and Other Arrangements": {
            "Purchase price payment partly in cash (in dollars per share)": {
                "value": 152.25, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Purchase price payment partly in fair market value of shares of acquirer's common stock (in dollars per share)": {
                "value": 109, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }, 
        "Pharmacyclics Inc | Scenario Two Collaborations and Other Arrangements": {
            "Purchase price payment fully in cash (in dollars per share)": {
                "value": 261.25, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }, 
        "Pharmacyclics Inc | Scenario Three Collaborations and Other Arrangements": {
            "Purchase price payment fully in fair market value of shares of acquirer's common stock (in dollars per share)": {
                "value": 261.25, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }, 
        "Pharmacyclics Inc | Subsequent event | Forecast Collaborations and Other Arrangements": {
            "Aggregate purchase price": {
                "value": 21000000000, 
                "time": "3 months ended", 
                "date": "jun 30 2015"
            }
        }
    }, 
    {
        "title": "Goodwill and Intangible Assets (Details) (USD $) In Millions, unless otherwise specified", 
        "Goodwill": {
            "Carrying amount of goodwill": [
                {
                    "value": 5534, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 5862, 
                    "date": "dec 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Accumulated goodwill impairment losses": {
                "value": 0, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }, 
        "Definite-lived intangible assets": {
            "Gross carrying amount": [
                {
                    "value": 5702, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 5643, 
                    "date": "dec 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Accumulated amortization": [
                {
                    "value": -4631, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -4575, 
                    "date": "dec 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Net carrying amount": [
                {
                    "value": 1071, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 1068, 
                    "date": "dec 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Indefinite-lived research and development": [
                {
                    "value": 407, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 445, 
                    "date": "dec 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Net carrying amount - Indefinite-lived research and development": [
                {
                    "value": 407, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 445, 
                    "date": "dec 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Total intangible assets gross carrying amount": [
                {
                    "value": 6109, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 6088, 
                    "date": "dec 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Accumulated amortization - Total intangible assets": [
                {
                    "value": -4631, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -4575, 
                    "date": "dec 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Total intangible assets": [
                {
                    "value": 1478, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 1513, 
                    "date": "dec 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Amortization of intangible assets": [
                {
                    "value": 68, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 110, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Impairment charges": [
                {
                    "value": 0, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 0, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Developed product rights Definite-lived intangible assets": {
            "Gross carrying amount": [
                {
                    "value": 4526, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 4546, 
                    "date": "dec 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Accumulated amortization": [
                {
                    "value": -3742, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -3706, 
                    "date": "dec 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Net carrying amount": [
                {
                    "value": 784, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 840, 
                    "date": "dec 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "License agreements Definite-lived intangible assets": {
            "Gross carrying amount": [
                {
                    "value": 1176, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 1097, 
                    "date": "dec 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Accumulated amortization": [
                {
                    "value": -889, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -869, 
                    "date": "dec 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Net carrying amount": [
                {
                    "value": 287, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 228, 
                    "date": "dec 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }
    }, 
    {
        "title": "Restructuring Plans (Details) (USD $) In Millions, unless otherwise specified", 
        "Restructuring Plans": {
            "Restructuring charges": {
                "value": 9, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }, 
        "Restructuring reserve activity": {
            "Restructuring Charges": {
                "value": 9, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }, 
        "Cost of goods sold | Restructuring Plan 2014 and Prior Years Restructuring Plans": {
            "Restructuring charges": {
                "value": 9, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }
    }, 
    {
        "title": "Financial Instruments and Fair Value Measures (Details) (USD $) In Millions, unless otherwise specified", 
        "Financial Instruments and Fair Value Measures": {
            "Number of outstanding derivative instruments containing credit risk contingent features": {
                "value": 0, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }, 
        "Derivative instruments, notional amount and fair value": {
            "Derivatives in asset position": [
                {
                    "value": 199, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 211, 
                    "date": "dec 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Derivatives in liability position": [
                {
                    "value": 93, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 243, 
                    "date": "dec 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Interest rate contracts | Fair value hedges | Long-term liabilities Derivative instruments, notional amount and fair value": {
            "Derivatives in liability position": [
                {
                    "value": 59, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 180, 
                    "date": "dec 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Designated as hedging instrument | Interest rate contracts | Fair value hedges Derivative instruments, notional amount and fair value": {
            "Notional amount of derivative instruments": [
                {
                    "value": 8000, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 8000, 
                    "date": "dec 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Designated as hedging instrument | Foreign currency forward exchange contracts | Prepaid expenses and other Derivative instruments, notional amount and fair value": {
            "Derivatives in asset position": [
                {
                    "value": 149, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 141, 
                    "date": "dec 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Designated as hedging instrument | Foreign currency forward exchange contracts | Cash flow hedges Derivative instruments, notional amount and fair value": {
            "Notional amount of derivative instruments": [
                {
                    "value": 915, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 1400, 
                    "date": "dec 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Approximate length of time over which accumulated gains and losses will be recognized in Cost of products sold": {
                "value": "12 months", 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }, 
        "Not designated as hedging instrument | Foreign currency forward exchange contracts Derivative instruments, notional amount and fair value": {
            "Notional amount of derivative instruments": [
                {
                    "value": 5000, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 6800, 
                    "date": "dec 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Not designated as hedging instrument | Foreign currency forward exchange contracts | Prepaid expenses and other Derivative instruments, notional amount and fair value": {
            "Derivatives in asset position": [
                {
                    "value": 50, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 70, 
                    "date": "dec 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Not designated as hedging instrument | Foreign currency forward exchange contracts | Accounts payable and accrued liabilities Derivative instruments, notional amount and fair value": {
            "Derivatives in liability position": [
                {
                    "value": 34, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 63, 
                    "date": "dec 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }
    }, 
    {
        "title": "Financial Instruments and Fair Value Measures (Details 2) (USD $) In Millions, unless otherwise specified", 
        "Gain (loss) on derivatives": {
            "Income (expense) and gain (loss) reclassified into or recorded in net earnings": [
                {
                    "value": -17, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 73, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Cash flow hedges | Designated as hedging instrument Gain (loss) on derivatives": {
            "Gain recognized in other comprehensive (loss) income": [
                {
                    "value": 87, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 21, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Foreign currency forward exchange contracts | Not designated as hedging instrument | Net foreign exchange loss (gain) Gain (loss) on derivatives": {
            "Income (expense) and gain (loss) reclassified into or recorded in net earnings": [
                {
                    "value": -169, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -1, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Foreign currency forward exchange contracts | Cash flow hedges | Cost of goods sold Gain (loss) on derivatives": {
            "Income (expense) and gain (loss) reclassified into or recorded in net earnings": [
                {
                    "value": 31, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -12, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Interest rate contracts | Fair value hedges | Interest expense (income), net Gain (loss) on derivatives": {
            "Income (expense) and gain (loss) reclassified into or recorded in net earnings": [
                {
                    "value": 121, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 86, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }
    }, 
    {
        "title": "Financial Instruments and Fair Value Measures (Details 3) (USD $)", 
        "In Millions, unless otherwise specified Assets": {
            "Derivatives in asset position": [
                {
                    "value": 199, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 211, 
                    "date": "dec 31 2014"
                }
            ]
        }, 
        "Liabilities": {
            "Derivatives in liability position": [
                {
                    "value": 34, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 63, 
                    "date": "dec 31 2014"
                }
            ]
        }, 
        "Fair value Assets": {
            "Short term investments": [
                {
                    "value": 129, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 145, 
                    "date": "dec 31 2014"
                }
            ], 
            "Total assets": [
                {
                    "value": 129, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 145, 
                    "date": "dec 31 2014"
                }
            ]
        }, 
        "Quoted prices in active markets for identical assets (Level 1) Assets": {
            "Short term investments": [
                {
                    "value": 47, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 68, 
                    "date": "dec 31 2014"
                }
            ], 
            "Total assets": [
                {
                    "value": 47, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 68, 
                    "date": "dec 31 2014"
                }
            ]
        }, 
        "Significant other observable inputs (Level 2) Assets": {
            "Short term investments": [
                {
                    "value": 16, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 13, 
                    "date": "dec 31 2014"
                }
            ], 
            "Total assets": [
                {
                    "value": 16, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 13, 
                    "date": "dec 31 2014"
                }
            ]
        }, 
        "Significant unobservable inputs (Level 3) Assets": {
            "Short term investments": [
                {
                    "value": 66, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 64, 
                    "date": "dec 31 2014"
                }
            ], 
            "Total assets": [
                {
                    "value": 66, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 64, 
                    "date": "dec 31 2014"
                }
            ]
        }, 
        "Recurring | Fair value Assets": {
            "Cash and equivalents": [
                {
                    "value": 7906, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 8348, 
                    "date": "dec 31 2014"
                }
            ], 
            "Equity securities": [
                {
                    "value": 15, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 13, 
                    "date": "dec 31 2014"
                }
            ], 
            "Total assets": [
                {
                    "value": 8120, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 8581, 
                    "date": "dec 31 2014"
                }
            ]
        }, 
        "Recurring | Fair value | Foreign Exchange Contract [Member] Assets": {
            "Derivatives in asset position": [
                {
                    "value": 199, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 211, 
                    "date": "dec 31 2014"
                }
            ]
        }, 
        "Recurring | Fair value | Time deposits Assets": {
            "Short term investments": {
                "value": 9, 
                "date": "dec 31 2014"
            }
        }, 
        "Recurring | Quoted prices in active markets for identical assets (Level 1) Assets": {
            "Cash and equivalents": [
                {
                    "value": 992, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 1214, 
                    "date": "dec 31 2014"
                }
            ], 
            "Equity securities": [
                {
                    "value": 15, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 13, 
                    "date": "dec 31 2014"
                }
            ], 
            "Total assets": [
                {
                    "value": 1007, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 1227, 
                    "date": "dec 31 2014"
                }
            ]
        }, 
        "Recurring | Significant other observable inputs (Level 2) Assets": {
            "Cash and equivalents": [
                {
                    "value": 6914, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 7134, 
                    "date": "dec 31 2014"
                }
            ], 
            "Total assets": [
                {
                    "value": 7113, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 7354, 
                    "date": "dec 31 2014"
                }
            ]
        }, 
        "Recurring | Significant other observable inputs (Level 2) | Foreign Exchange Contract [Member] Assets": {
            "Derivatives in asset position": [
                {
                    "value": 199, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 211, 
                    "date": "dec 31 2014"
                }
            ]
        }, 
        "Recurring | Significant other observable inputs (Level 2) | Time deposits Assets": {
            "Short term investments": {
                "value": 9, 
                "date": "dec 31 2014"
            }
        }
    }, 
    {
        "title": "Financial Instruments and Fair Value Measures (Details 4) (USD $)", 
        "In Millions, unless otherwise specified Transfers of assets or liabilities between the fair value measurement levels": {
            "Transfer of assets from level 1 to level 2": {
                "value": 0, 
                "date": "mar 31 2015"
            }, 
            "Transfer of assets from level 2 to level 1": {
                "value": 0, 
                "date": "mar 31 2015"
            }, 
            "Transfer of liabilities from level 1 to level 2": {
                "value": 0, 
                "date": "mar 31 2015"
            }, 
            "Transfer of liabilities from level 2 to level 1": {
                "value": 0, 
                "date": "mar 31 2015"
            }
        }
    }, 
    {
        "title": "Financial Instruments and Fair Value Measures (Details 5) (USD $)", 
        "In Millions, unless otherwise specified Book values Assets": {
            "Investments": [
                {
                    "value": 96, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 95, 
                    "date": "dec 31 2014"
                }
            ]
        }, 
        "Liabilities": {
            "Short-term borrowings": [
                {
                    "value": 569, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 425, 
                    "date": "dec 31 2014"
                }
            ], 
            "Current portion of long-term debt and lease obligations": [
                {
                    "value": 4029, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 4033, 
                    "date": "dec 31 2014"
                }
            ], 
            "Long-term debt and lease obligations, excluding fair value hedges": [
                {
                    "value": 10893, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 10830, 
                    "date": "dec 31 2014"
                }
            ]
        }, 
        "Fair value Assets": {
            "Investments": [
                {
                    "value": 129, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 145, 
                    "date": "dec 31 2014"
                }
            ]
        }
    }, 
    {
        "title": "Financial Instruments and Fair Value Measures (Details 6) (USD $)", 
        "In Millions, unless otherwise specified Fair value Assets": {
            "Investments": [
                {
                    "value": 129, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 145, 
                    "date": "dec 31 2014"
                }
            ], 
            "Total assets": [
                {
                    "value": 129, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 145, 
                    "date": "dec 31 2014"
                }
            ]
        }, 
        "Liabilities": {
            "Short-term borrowings": [
                {
                    "value": 569, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 425, 
                    "date": "dec 31 2014"
                }
            ], 
            "Current portion of long-term debt and lease obligations": [
                {
                    "value": 22, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 21, 
                    "date": "dec 31 2014"
                }
            ], 
            "Long-term debt and lease obligations, excluding fair value hedges": [
                {
                    "value": 90, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 93, 
                    "date": "dec 31 2014"
                }
            ], 
            "Total liabilities": [
                {
                    "value": 681, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 539, 
                    "date": "dec 31 2014"
                }
            ]
        }, 
        "Quoted prices in active markets for identical assets (Level 1) Assets": {
            "Investments": [
                {
                    "value": 47, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 68, 
                    "date": "dec 31 2014"
                }
            ], 
            "Total assets": [
                {
                    "value": 47, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 68, 
                    "date": "dec 31 2014"
                }
            ]
        }, 
        "Significant other observable inputs (Level 2) Assets": {
            "Investments": [
                {
                    "value": 16, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 13, 
                    "date": "dec 31 2014"
                }
            ], 
            "Total assets": [
                {
                    "value": 16, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 13, 
                    "date": "dec 31 2014"
                }
            ]
        }, 
        "Significant unobservable inputs (Level 3) Assets": {
            "Investments": [
                {
                    "value": 66, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 64, 
                    "date": "dec 31 2014"
                }
            ], 
            "Total assets": [
                {
                    "value": 66, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 64, 
                    "date": "dec 31 2014"
                }
            ]
        }
    }, 
    {
        "title": "Financial Instruments and Fair Value Measures (Details 7) In Millions, unless otherwise specified", 
        "Concentration of Risk": {
            "Number of principal customers": [
                {
                    "value": 3, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 3, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }
            ], 
            "Concentrations risk (as a percent)": [
                {
                    "value": 0.48, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 0.49, 
                    "time": "12 months ended", 
                    "date": "dec 31 2014"
                }, 
                {
                    "value": 0.62, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 0.58, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Net governmental receivables outstanding": [
                {
                    "value": 479, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 446, 
                    "date": "dec 31 2014"
                }
            ], 
            "Net monetary assets": {
                "value": 265, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Net sales": [
                {
                    "value": 5040, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 4563, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 46, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }
            ], 
            "Exchange rate": [
                {
                    "value": 6.3, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 12, 
                    "date": "mar 31 2015"
                }
            ], 
            "Asset devaluation loss": {
                "value": 126, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }
    }, 
    {
        "title": "Financial Instruments and Fair Value Measures (Detail 8) (USD $)", 
        "Short-term Debt [Line Items]": {
            "Short-term Debt": [
                {
                    "value": 569000000, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 425000000, 
                    "date": "dec 31 2014"
                }
            ]
        }, 
        "Revolving Credit Facility [Member] Short-term Debt [Line Items]": {
            "Line of Credit Facility, Maximum Borrowing Capacity": {
                "value": 3000000000, 
                "date": "mar 31 2015"
            }, 
            "Line of Credit Facility, Amount Outstanding": [
                {
                    "value": 0, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 0, 
                    "date": "dec 31 2014"
                }
            ]
        }, 
        "Commercial Paper Short-term Debt [Line Items]": {
            "Short-term Debt": [
                {
                    "value": 569000000, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 416000000, 
                    "date": "dec 31 2014"
                }
            ], 
            "Short-term Debt, Weighted Average Interest Rate": [
                {
                    "value": 0.003, 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 0.002, 
                    "date": "mar 31 2014"
                }
            ]
        }, 
        "Bridge Term Loan Agreement | Term loan facility Short-term Debt [Line Items]": {
            "Line of Credit Facility, Maximum Borrowing Capacity": {
                "value": 18000000000, 
                "date": "mar 27 2015"
            }
        }
    }, 
    {
        "title": "Post-Employment Benefits (Details) (AbbVie sponsored plans, USD $) In Millions, unless otherwise specified", 
        "Post-Employment Benefits": {
            "Contribution by employer": [
                {
                    "value": 150, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 370, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Defined benefit plans Post-Employment Benefits": {
            "Service cost": [
                {
                    "value": 58, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 43, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Interest cost": [
                {
                    "value": 56, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 55, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Expected return on plan assets": [
                {
                    "value": -81, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -75, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Amortization of actuarial losses (gains) and prior service costs": [
                {
                    "value": 34, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 17, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Net periodic benefit cost": [
                {
                    "value": 67, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 40, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Other post-employment plans Post-Employment Benefits": {
            "Service cost": [
                {
                    "value": 6, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 5, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Interest cost": [
                {
                    "value": 6, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 6, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Amortization of actuarial losses (gains) and prior service costs": [
                {
                    "value": 1, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -1, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Net periodic benefit cost": [
                {
                    "value": 13, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 10, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }
    }, 
    {
        "title": "Equity (Details) (USD $) In Millions, except Share data in Thousands, unless otherwise specified", 
        "Stock-Based Compensation": {
            "Stock compensation expense recognized": [
                {
                    "value": 119, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 106, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Abbott Stock-Based Compensation": {
            "Number of awards received in connection with the separation": {
                "value": 1, 
                "time": "0 months ended", 
                "date": "jan 02 2013"
            }, 
            "Number of awards granted to employees other than in connection with the separation": {
                "value": 0, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }, 
        "Stock Options Stock-Based Compensation": {
            "Exercise price for awards granted as percentage of market value on the date of grant": {
                "value": 1, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Contractual term": {
                "value": "10 years", 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Weighted-average grant-date fair value of the stock options granted": [
                {
                    "value": 9.96, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 9.83, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Options": {
            "Outstanding at the beginning of the period (in shares)": {
                "value": 28280, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Granted (in shares)": {
                "value": 1205, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Exercised (in shares)": {
                "value": -2356, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Lapsed (in shares)": {
                "value": -34, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Outstanding at the end of the period (in shares)": [
                {
                    "value": 27095, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 28280, 
                    "time": "12 months ended", 
                    "date": "dec 31 2014"
                }
            ], 
            "Exercisable at the end of the period (in shares)": {
                "value": 24579, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }, 
        "Weighted average exercise price": {
            "Outstanding at the beginning of the period (in dollars per share)": {
                "value": 28.53, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Granted (in dollars per share)": {
                "value": 58.88, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Exercised (in dollars per share)": {
                "value": 25.03, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Lapsed (in dollars per share)": {
                "value": 25.92, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Outstanding at the end of the period (in dollars per share)": [
                {
                    "value": 30.19, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 28.53, 
                    "time": "12 months ended", 
                    "date": "dec 31 2014"
                }
            ], 
            "Exercisable at the end of the period (in dollars per share)": {
                "value": 27.99, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }, 
        "Weighted average remaining life (in years)": {
            "Outstanding at the end of the period": [
                {
                    "value": "3 years 7 months 6 days", 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": "3 years 3 months 18 days", 
                    "time": "12 months ended", 
                    "date": "dec 31 2014"
                }
            ], 
            "Exercisable at end of the period": {
                "value": "3 years", 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }, 
        "Aggregate intrinsic value": {
            "Outstanding at the end of the period": [
                {
                    "value": 768, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 1044, 
                    "time": "12 months ended", 
                    "date": "dec 31 2014"
                }
            ], 
            "Exercisable at the end of the period": {
                "value": 751, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }, 
        "Additional information": {
            "Fair market value of awards vested": [
                {
                    "value": 310, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 314, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Unrecognized compensation cost": {
                "value": 303, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }, 
        "RSAs & RSUs Additional information": {
            "Period for recognition of unrecognized compensation cost": {
                "value": "2 years", 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }, 
        "Share units": {
            "Unvested shares at the beginning of the period (in shares)": {
                "value": 12815, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Granted (in shares)": {
                "value": 4336, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Vested (in shares)": {
                "value": -5293, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Lapsed (in shares)": {
                "value": -155, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Outstanding at the end of the period (in shares)": {
                "value": 11703, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }, 
        "Weighted average grant date fair value": {
            "Unvested shares at the beginning of the period (in dollars per share)": {
                "value": 40.98, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Granted (in dollars per share)": {
                "value": 58.89, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Vested (in dollars per share)": {
                "value": 36.99, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Lapsed (in dollars per share)": {
                "value": 44.42, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Outstanding at the end of the period (in dollars per share)": {
                "value": 49.37, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }
    }, 
    {
        "title": "Equity (Details 2) (USD $)", 
        "Cash Dividends": {
            "Dividends declared (in dollars per share)": {
                "value": 0.49, 
                "time": "3 months ended", 
                "date": "dec 31 2014"
            }, 
            "Percentage increase in dividends declared": {
                "value": 0.17, 
                "time": "3 months ended", 
                "date": "dec 31 2014"
            }
        }, 
        "Quarter One Dividends Payable": {
            "Date declared": [
                {
                    "value": "19-Feb-15", 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": "20-Feb-14", 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Date of record": {
                "value": "15-Apr-15", 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Date paid": [
                {
                    "value": "15-May-15", 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": "14-Feb-14", 
                    "date": "dec 31 2013", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Quarter Two Dividends Payable": {
            "Date paid": {
                "value": "15-May-14", 
                "date": "mar 31 2014"
            }
        }, 
        "Quarter Three Cash Dividends": {
            "Dividends declared (in dollars per share)": {
                "value": 0.42, 
                "time": "3 months ended", 
                "date": "sep 30 2014"
            }
        }, 
        "Quarter Four Dividends Payable": {
            "Date declared": [
                {
                    "value": "20-Oct-14", 
                    "time": "3 months ended", 
                    "date": "dec 31 2014"
                }, 
                {
                    "value": "12-Dec-13", 
                    "date": "dec 31 2013", 
                    "time": "3 months ended"
                }
            ], 
            "Date of record": {
                "value": "15-Jan-15", 
                "time": "3 months ended", 
                "date": "dec 31 2014"
            }, 
            "Date paid": {
                "value": "13-Feb-15", 
                "time": "3 months ended", 
                "date": "dec 31 2014"
            }
        }
    }, 
    {
        "title": "Equity (Details 3) (USD $) Share data in Millions, unless otherwise specified", 
        "Stock Repurchase Program": {
            "Amount authorized under stock repurchase program": [
                {
                    "value": 5000000000, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 5000000000, 
                    "date": "oct 20 2014", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 1500000000, 
                    "date": "feb 15 2013", 
                    "time": "3 months ended"
                }
            ], 
            "Shares repurchased": [
                {
                    "value": 4, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 5, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Payment for shares repurchased on the open market": [
                {
                    "value": 250000000, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 250000000, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Share repurchase authorization amount remaining": {
                "value": 9400000000, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }, 
        "Changes in accumulated other comprehensive Income": {
            "Beginning balance": [
                {
                    "value": -2031000000, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -442000000, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Other comprehensive (loss) income before reclassifications": [
                {
                    "value": -431000000, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -8000000, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Amounts reclassified from accumulated other comprehensive loss": [
                {
                    "value": -5000000, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 24000000, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Other comprehensive (loss) income": [
                {
                    "value": -436000000, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 16000000, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Ending balance": [
                {
                    "value": -2467000000, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -426000000, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Foreign currency translation adjustments Changes in accumulated other comprehensive Income": {
            "Beginning balance": [
                {
                    "value": -603000000, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 470000000, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Other comprehensive (loss) income before reclassifications": [
                {
                    "value": -549000000, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -29000000, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Other comprehensive (loss) income": [
                {
                    "value": -549000000, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -29000000, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Ending balance": [
                {
                    "value": -1152000000, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 441000000, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Pension and post-employment benefits Changes in accumulated other comprehensive Income": {
            "Beginning balance": [
                {
                    "value": -1608000000, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -827000000, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Other comprehensive (loss) income before reclassifications": {
                "value": 30000000, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Amounts reclassified from accumulated other comprehensive loss": [
                {
                    "value": 25000000, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 12000000, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Other comprehensive (loss) income": [
                {
                    "value": 55000000, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 12000000, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Ending balance": [
                {
                    "value": -1553000000, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -815000000, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Unrealized gains (losses) on marketable equity securities Changes in accumulated other comprehensive Income": {
            "Beginning balance": [
                {
                    "value": 3000000, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 2000000, 
                    "date": "dec 31 2013", 
                    "time": "3 months ended"
                }
            ], 
            "Other comprehensive (loss) income before reclassifications": {
                "value": 1000000, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Other comprehensive (loss) income": {
                "value": 1000000, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Ending balance": [
                {
                    "value": 4000000, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 2000000, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }, 
                {
                    "value": 2000000, 
                    "date": "dec 31 2013", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Gains (losses) on hedging activities Changes in accumulated other comprehensive Income": {
            "Beginning balance": [
                {
                    "value": 177000000, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -87000000, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Other comprehensive (loss) income before reclassifications": [
                {
                    "value": 87000000, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 21000000, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Amounts reclassified from accumulated other comprehensive loss": [
                {
                    "value": -30000000, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 12000000, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Other comprehensive (loss) income": [
                {
                    "value": 57000000, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 33000000, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Ending balance": [
                {
                    "value": 234000000, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -54000000, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }
    }, 
    {
        "title": "Equity (Details 4) (USD $) In Millions, unless otherwise specified", 
        "Pension and post-employment benefits Significant amounts reclassified out of each component of AOCI": {
            "Amortization of actuarial losses and other": [
                {
                    "value": 35, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 16, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Less tax benefit": [
                {
                    "value": -10, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": -4, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Total reclassification, net of tax": [
                {
                    "value": 25, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 12, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Gains (losses) on hedging activities Significant amounts reclassified out of each component of AOCI": {
            "(Gains) losses on designated cash flow hedges": [
                {
                    "value": -31, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 12, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Less tax expense": {
                "value": 1, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Total reclassification, net of tax": [
                {
                    "value": -30, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 12, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }
    }, 
    {
        "title": "Income Taxes (Details) (USD $) In Millions, unless otherwise specified", 
        "Income Taxes": {
            "Effective tax rate (as a percent)": [
                {
                    "value": 0.27, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 0.24, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ], 
            "Statutory tax rate (as a percent)": {
                "value": 0.35, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Reasonably possible amount that gross unrecognized tax benefits may change within the next twelve months, high end of range": {
                "value": 21, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }
    }, 
    {
        "title": "Legal Proceedings and Contingencies (Details)", 
        "Legal Proceedings and Contingencies": {
            "Number of individual putative class action lawsuit": {
                "value": 5, 
                "time": "1 months ended", 
                "date": "nov 30 2014"
            }
        }, 
        "Depakote | Sidney Hillman Health Center of Rochester, et al. v. AbbVie Inc., et al. Legal Proceedings and Contingencies": {
            "Number of healthcare benefit providers who filed lawsuits": {
                "value": 3, 
                "date": "aug 31 2013"
            }, 
            "Number of generic companies with whom certain litigation related agreements were entered into": {
                "value": 3, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }, 
        "HUMIRA patent infringement claim, NYU and Centocor | AndroGel Antitrust Litigation Legal Proceedings and Contingencies": {
            "Number of individual plaintiff lawsuits": {
                "value": 3, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }, 
            "Number of purported class actions": {
                "value": 7, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }, 
        "Allegation of proposed generic products infringing AbbVie's patents and seeking declaratory and injunctive relief | Matrix Laboratories, Inc.'s, Matrix Laboratories, Ltd.'s, and Mylan, Inc.'s case Legal Proceedings and Contingencies": {
            "Stay period": {
                "value": "5 years", 
                "time": "1 months ended", 
                "date": "nov 30 2009"
            }
        }
    }, 
    {
        "title": "Segment Information (Details) (USD $) In Millions, unless otherwise specified", 
        "Segment Information": {
            "Net sales": [
                {
                    "value": 5040, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 4563, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "HUMIRA Segment Information": {
            "Net sales": [
                {
                    "value": 3111, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 2637, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Synagis Segment Information": {
            "Net sales": [
                {
                    "value": 335, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 354, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "VIEKIRA Segment Information": {
            "Net sales": {
                "value": 231, 
                "time": "3 months ended", 
                "date": "mar 31 2015"
            }
        }, 
        "Lupron Segment Information": {
            "Net sales": [
                {
                    "value": 192, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 189, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Synthroid Segment Information": {
            "Net sales": [
                {
                    "value": 186, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 157, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Kaletra Segment Information": {
            "Net sales": [
                {
                    "value": 180, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 195, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "AndroGel Segment Information": {
            "Net sales": [
                {
                    "value": 153, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 254, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Creon Segment Information": {
            "Net sales": [
                {
                    "value": 127, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 107, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Sevoflurane Segment Information": {
            "Net sales": [
                {
                    "value": 126, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 142, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Duodopa Segment Information": {
            "Net sales": [
                {
                    "value": 53, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 52, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "Dyslipidemia products Segment Information": {
            "Net sales": [
                {
                    "value": 43, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 96, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }, 
        "All other Segment Information": {
            "Net sales": [
                {
                    "value": 303, 
                    "time": "3 months ended", 
                    "date": "mar 31 2015"
                }, 
                {
                    "value": 380, 
                    "date": "mar 31 2014", 
                    "time": "3 months ended"
                }
            ]
        }
    }
]